Showing results (2841-2850 of 13,600) with videos related to
Sort By:
Pageof 1,360
Atherosclerosis|March 21, 2006
Association of heterozygous familial hypercholesterolemia with smaller HDL particle sizeJean-Charles Hogue, Benoît Lamarche, Daniel Gaudet, et al.Atherosclerosis|March 21, 2006
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in GermanyS Böhler, H Scharnagl, F Freisinger, et al.Atherosclerosis|March 21, 2006
Nitric oxide production is paradoxically decreased after weight reduction surgery in morbid obesity patientsLian-Yu Lin, Wei-Jei Lee, Hsiu-Nien Shen, et al.Atherosclerosis|December 22, 2007
Paraoxonase (PON1) is associated with familial combined hyperlipidemiaThomas M van Himbergen, Lambertus J H van Tits, Ewoud Ter Avest, et al.Atherosclerosis|October 15, 2016
Endophilin-A2-mediated increase in scavenger receptor expression contributes to macrophage-derived foam cell formationEr-Wen Huang, Can-Zhao Liu, Si-Jia Liang, et al.Atherosclerosis|August 1, 1989
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDLP Schuff-Werner, G Claus, V W Armstrong, et al.Atherosclerosis|August 1, 1989
Factor, present in plasma, inhibiting the interaction of low density lipoprotein with arterial proteoglycanH J Kempen, M Buytenhek, E Gruber, et al.Atherosclerosis|August 1, 1989
Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aortaR Feliste, B Perret, P Braquet, et al.Atherosclerosis|August 1, 1989
Primary prevention of atherosclerosis by lovastatin in a genetically hyperlipidaemic rabbit strainA E La Ville, A M Seddon, M Shaikh, et al.Atherosclerosis|August 1, 1989
Carbon disulfide modification and impaired catabolism of low density lipoproteinW Laurman, S Salmon, C Mazière, et al.Pageof 1,360